Juq-578 -

JUQ‑578 represents a with a unique capacity to cross the blood‑brain barrier while retaining high potency and a favorable safety profile. Its dual‑action potential—attenuating neuroinflammation in CNS disorders and dampening systemic inflammation in metabolic disease—positions it as a first‑in‑class oral therapeutic that could fill a critical gap in current treatment paradigms. The upcoming Phase I program will be pivotal in confirming its translational viability, and, if successful, JUQ‑

: Support your review with facts or personal experiences. If you're evaluating a product, for instance, mention how you used it and what you liked or disliked. JUQ-578